Molecular red cell genotyping of rare blood donors in South Africa to enhance rare donor-patient blood matching.

Targeted screening of donors for antigen-negative rare blood units for patients should be done to reduce the risk of haemolytic transfusion reactions and haemolytic disease of the foetus and newborn.